Medication-Assisted Treatment - Prescription Drug and Opioid Addiction

The Medication Assisted Treatment Prescription Drug and Opioid Addiction program is administered by the Substance Abuse and Mental Health Services Administration within the U.S. Department of Health and Human Services. This federal funding opportunity is designed to address the ongoing opioid crisis in the United States by expanding access to evidence based treatment for individuals with opioid use disorder. SAMHSA plays a central role in advancing behavioral health nationwide, and this program aligns with its broader strategic priorities focused on prevention, treatment access, recovery support, and data driven outcomes. The primary purpose of the program is to expand and enhance access to medications for opioid use disorder, including methadone, buprenorphine, and naltrexone, while integrating these treatments with comprehensive psychosocial services. The initiative aims to increase treatment availability, reduce illicit opioid use, decrease prescription opioid misuse, and lower overdose rates. Applicants are expected to provide clinically appropriate services that include screening, diagnosis using DSM criteria, individualized treatment planning, and ongoing recovery support. The program emphasizes integrated care models, partnerships with community organizations, and outreach to underserved populations. Funding for this opportunity is substantial, with an estimated total program allocation exceeding sixty eight million dollars and individual awards of up to seven hundred fifty thousand dollars per year for a project period of up to five years. This creates the potential for multi year funding approaching three million seven hundred fifty thousand dollars per award. Funds are primarily intended for direct service delivery and must be used in accordance with federal regulations and SAMHSA priorities. Certain restrictions apply, including limitations on funding for specific medications, prohibitions on certain programmatic approaches, and requirements for alignment with federal policy directives. Eligibility for the program is broad and includes states, territories, political subdivisions, tribal governments and organizations, health facilities, and public or private nonprofit organizations including faith based entities. Applicants must demonstrate experience, appropriate licensure, and the capacity to deliver required services. Organizations that previously received funding under specific earlier program announcements are not eligible. Cost sharing is not required, which lowers the financial barrier to participation for eligible applicants. The application process is structured and requires completion of multiple components, including a project narrative, budget narrative, and several required attachments such as letters of commitment, data collection plans, and organizational documentation. Applicants must register in federal systems including SAM.gov, Grants.gov, and eRA Commons prior to submission. Applications are evaluated through a merit review process based on criteria such as need, implementation approach, evidence based practices, organizational capacity, and data collection plans. Additional considerations include alignment with SAMHSA priorities and geographic factors that may provide bonus scoring. The timeline for this opportunity includes a firm application deadline in late July with expected award decisions in early September and a project start date at the end of September. Successful applicants must begin service delivery within four months of award and adhere to ongoing reporting requirements, including regular data submission and progress reporting. The program is expected to operate on an annual funding cycle, with continuation dependent on performance and availability of funds. Contacts are provided for programmatic, financial, and review related inquiries through SAMHSA offices, ensuring applicants have access to support throughout the application process.

Ensure strong alignment with SAMHSA strategic priorities and clearly demonstrate evidence based practices and measurable outcomes Include detailed implementation and data collection plans and confirm organizational capacity and partnerships